Craig-Hallum Maintains Buy on MiMedx Group, Lowers Price Target to $7
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $10 to $7.
Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $10 to $7.